ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,127.79
      1.26%
      US Tech 100
      17,446.00
      2.17%
      Dow Jones
      38,675.68
      1.18%
      Brent Oil
      83.025
      -0.12%
      Bitcoin
      64,102.59
      0.16%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Cabaletta Bio Inc (CABA)

      7. Cabaletta Bio Inc (CABA) News

      CABA

      Cabaletta Bio (CABA)

      Cabaletta Bio Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:CABA
      DateTimeSourceHeadlineSymbolCompany
      03/21/20247:00AMGlobeNewswire Inc.Cabaletta Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:CABACabaletta Bio Inc
      03/20/20247:00AMGlobeNewswire Inc.Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Systemic SclerosisNASDAQ:CABACabaletta Bio Inc
      03/04/20245:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CABACabaletta Bio Inc
      03/04/20245:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CABACabaletta Bio Inc
      03/04/20245:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CABACabaletta Bio Inc
      03/04/20245:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CABACabaletta Bio Inc
      03/04/20245:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CABACabaletta Bio Inc
      02/27/20248:00AMGlobeNewswire Inc.Cabaletta Bio to Participate in Upcoming Investor Conferences in MarchNASDAQ:CABACabaletta Bio Inc
      02/14/20249:20AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CABACabaletta Bio Inc
      02/13/20246:47PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CABACabaletta Bio Inc
      02/01/20244:36PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CABACabaletta Bio Inc
      02/01/20244:30PMGlobeNewswire Inc.Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of MyositisNASDAQ:CABACabaletta Bio Inc
      01/31/20248:00AMGlobeNewswire Inc.Cabaletta Bio to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceNASDAQ:CABACabaletta Bio Inc
      01/19/20246:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CABACabaletta Bio Inc
      01/08/20247:11AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CABACabaletta Bio Inc
      01/08/20247:00AMGlobeNewswire Inc.Cabaletta Bio Receives Additional FDA Fast Track Designations for CABA-201 in Dermatomyositis and Systemic SclerosisNASDAQ:CABACabaletta Bio Inc
      01/02/20248:00AMGlobeNewswire Inc.Cabaletta Bio to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:CABACabaletta Bio Inc
      12/19/20238:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CABACabaletta Bio Inc
      11/29/20236:18AMIH Market NewsAmazon Unveils Innovative Services, Okta Discloses Data Breach, Textron Plans 2% Global Workforce Reduction, and MoreNASDAQ:CABACabaletta Bio Inc
      11/28/20234:30PMGlobeNewswire Inc.Cabaletta Bio to Participate in the 6th Annual Evercore ISI HealthCONx ConferenceNASDAQ:CABACabaletta Bio Inc
      11/28/20232:59PMDow Jones NewsCabaletta Bio Down as FDA Looks Into Issues With Several Companies' Approved CAR T DrugsNASDAQ:CABACabaletta Bio Inc
      11/21/20234:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CABACabaletta Bio Inc
      11/20/20234:16PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CABACabaletta Bio Inc
      11/09/20237:24AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CABACabaletta Bio Inc
      11/09/20237:12AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CABACabaletta Bio Inc
      11/09/20237:00AMGlobeNewswire Inc.Cabaletta Bio Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:CABACabaletta Bio Inc
      11/06/20238:15AMBusiness WireCellares and Cabaletta Bio Partner to Evaluate Automated Manufacturing for CABA-201, Cabaletta’s CD19-CAR T Cell Therapy on Cellares’ Cell Shuttle PlatformNASDAQ:CABACabaletta Bio Inc
      11/06/20237:55AMDow Jones NewsCabaletta Bio Gets FDA OK to Study CABA-201 in Generalized Myasthenia GravisNASDAQ:CABACabaletta Bio Inc
      11/06/20237:03AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CABACabaletta Bio Inc
      11/06/20237:00AMGlobeNewswire Inc.Cabaletta Bio Receives FDA Clearance of CABA-201 IND Application for Treatment of Generalized Myasthenia GravisNASDAQ:CABACabaletta Bio Inc
       Showing the most relevant articles for your search:NASDAQ:CABA